to lowering an individual’s risk of Alzheimer’s disease. This analysis was conducted by researchers at Case Western Reserve ...

A group of international experts is challenging revised diagnostic criteria for Alzheimer’s disease (AD) as laid out by the ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Diagnosis of Alzheimer's Disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted.

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...